Wave Historical Financial Ratios
| WVE Stock | USD 15.10 0.11 0.73% |
Wave Life is currently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 4.49, Dividend Yield of 0.0, PTB Ratio of 16.29 or Days Sales Outstanding of 58.08 will help investors to properly organize and evaluate Wave Life Sciences financial condition quickly.
Wave |
About Wave Financial Ratios Analysis
Wave Life SciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Wave Life investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Wave financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Wave Life history.
Wave Life Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Wave Life Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Wave Life sales, a figure that is much harder to manipulate than other Wave Life Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Most ratios from Wave Life's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Wave Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At present, Wave Life's PB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Inventory Turnover is expected to grow to 16.30, whereas Days Sales Outstanding is forecasted to decline to 58.08.
| 2023 | 2024 (projected) | Payables Turnover | 0.72 | 0.68 | Days Of Inventory On Hand | 27.6 | 20.3 |
Wave Life fundamentals Correlations
Click cells to compare fundamentals
Wave Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Wave Life fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 16.99 | 15.38 | 3.97 | 151.27 | 4.73 | 4.49 | |
| Ptb Ratio | 4.26 | 3.73 | 5.01 | (12.24) | 11.28 | 16.29 | |
| Days Sales Outstanding | 253.23 | 456.74 | 545.4 | 67.93 | 61.13 | 58.08 | |
| Book Value Per Share | 1.88 | 2.11 | 0.63 | (0.57) | 0.45 | 0.43 | |
| Free Cash Flow Yield | (0.71) | (0.38) | (0.55) | (0.23) | (0.0383) | (0.0403) | |
| Operating Cash Flow Per Share | (5.56) | (2.96) | (1.72) | (1.62) | (0.18) | (0.19) | |
| Stock Based Compensation To Revenue | 1.22 | 0.71 | 0.4 | 4.71 | 0.0864 | 0.0821 | |
| Capex To Depreciation | 8.76 | 1.78 | 0.43 | 0.13 | 0.0569 | 0.12 | |
| Pb Ratio | 4.26 | 3.73 | 5.01 | (12.24) | 11.28 | 16.29 | |
| Ev To Sales | 9.82 | 7.65 | 1.03 | 137.33 | 3.24 | 3.08 | |
| Free Cash Flow Per Share | (1.13) | (5.67) | (2.99) | (1.73) | (0.19) | (0.2) | |
| Roic | (2.88) | (1.76) | (3.39) | 4.13 | (1.24) | (1.3) | |
| Net Income Per Share | (5.3) | (3.82) | (2.36) | (2.05) | (0.54) | (0.57) | |
| Payables Turnover | 19.34 | 9.0 | 16.74 | 0.6 | 0.72 | 0.68 | |
| Sales General And Administrative To Revenue | 3.06 | 2.12 | 1.13 | 13.84 | 0.45 | 0.43 | |
| Research And Ddevelopement To Revenue | 10.98 | 6.52 | 2.98 | 31.75 | 1.15 | 1.09 | |
| Capex To Revenue | 0.25 | 0.0666 | 0.0137 | 0.37 | 0.009841 | 0.009349 | |
| Cash Per Share | 4.35 | 4.7 | 2.91 | 1.12 | 1.89 | 1.79 | |
| Pocfratio | (1.44) | (2.66) | (1.83) | (4.32) | (27.57) | (28.95) | |
| Capex To Operating Cash Flow | (0.0208) | (0.0115) | (0.006293) | (0.0107) | (0.0574) | (0.0603) | |
| Pfcf Ratio | (1.41) | (2.63) | (1.82) | (4.27) | (26.08) | (27.38) | |
| Days Payables Outstanding | 18.88 | 40.55 | 21.81 | 610.44 | 509.04 | 600.83 | |
| Income Quality | 0.97 | 0.77 | 0.73 | 0.79 | 0.34 | 0.32 | |
| Roe | (2.82) | (1.81) | (3.76) | 3.59 | (1.21) | (1.27) | |
| Ev To Operating Cash Flow | (0.83) | (1.32) | (0.47) | (3.92) | (18.92) | (19.86) | |
| Pe Ratio | (1.51) | (2.06) | (1.33) | (3.41) | (9.32) | (9.78) | |
| Return On Tangible Assets | (0.63) | (0.54) | (0.59) | (1.11) | (0.21) | (0.22) | |
| Ev To Free Cash Flow | (0.82) | (1.31) | (0.47) | (3.88) | (17.89) | (18.78) | |
| Net Debt To E B I T D A | 0.57 | 1.08 | 1.03 | 0.33 | 2.86 | 3.0 | |
| Current Ratio | 1.57 | 1.9 | 2.53 | 1.38 | 1.26 | 1.2 | |
| Tangible Book Value Per Share | 1.88 | 2.11 | 0.63 | (0.57) | 0.45 | 0.43 | |
| Receivables Turnover | 1.44 | 0.8 | 0.67 | 5.37 | 4.84 | 5.08 | |
| Graham Number | 14.98 | 13.47 | 5.77 | 5.14 | 2.34 | 2.22 | |
| Shareholders Equity Per Share | 1.88 | 2.11 | 0.63 | (0.57) | 0.45 | 0.43 | |
| Debt To Equity | 0.0221 | 0.14 | 0.0509 | 0.0449 | 0.15 | (0.12) | |
| Capex Per Share | 0.12 | 0.0341 | 0.0108 | 0.0173 | 0.0105 | 0.009984 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.11) | Return On Assets (0.34) | Return On Equity (2.44) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.